{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:26:35Z","timestamp":1794489995034,"version":"4.9.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Chemotherapy has been proposed as an adjunct to primary local therapy in esthesioneuroblastoma (ENB)\/olfactory neuroblastoma (ON), but its role has not been precisely defined. Here, we evaluated its role in ENB treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>The Surveillance Epidemiology and End Results (SEER) database was queried for ENB\/ON (International Classification of Diseases-3 9522). Cases met criteria for inclusion if they were unique, had a primary location in the nasal cavity, and had adequate information for Kadish staging derivation. Univariable and multivariable Cox analyses assessed chemotherapy treatment effect on disease-specific survival (DSS) and overall survival (OS). Multiple imputation addressed missing data. A <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05 was designated for statistical significance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In adjusted multivariable analyses, chemotherapy treatment was associated with inferior DSS (hazard ratio [HR], 1.74; 95% confidence interval [CI], 1.21-2.51; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.003) and OS (HR, 1.71; 95% CI, 1.26-2.32; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001). Among the subset with local or regional disease treated with surgery and\/or radiation therapy, chemotherapy remained associated with inferior outcomes DSS (HR, 2.78; 95% CI, 1.63-4.74; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and OS (HR, 2.18; 95% CI, 1.45-3.27; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Chemotherapy treatment misclassification did not explain these findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This analysis does not support chemotherapy to improve either DSS or OS in primary ENB\/ON treatment, after controlling for known ENB prognostic factors available from SEER. Other prognostic and treatment selection factors could exist which were not controlled in these analyses. Chemotherapy could beneficially affect outcomes other than DSS or OS. Although the concerns have been expressed regarding chemotherapy treatment misclassification in SEER, their analyses did not identify such misclassification as an explanation for our findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000649","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T11:24:51Z","timestamp":1576495491000},"page":"203-209","source":"Crossref","is-referenced-by-count":27,"title":["Chemotherapy in Esthesioneuroblastoma\/Olfactory Neuroblastoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Lee D.","family":"Cranmer","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Oncology"},{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonny","family":"Chau","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Rockhill","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay J.","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12105-009-0125-2","article-title":"Olfactory neuroblastoma","volume":"3","author":"Thompson","year":"2009","journal-title":"Head Neck Pathol"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hed.21830","article-title":"Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data","volume":"34","author":"Turner","year":"2012","journal-title":"Head Neck"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/cncr.10537","article-title":"Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy","volume":"94","author":"Fitzek","year":"2002","journal-title":"Cancer"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/alr.22229","article-title":"Role of induction chemotherapy in sinonasal malignancies: a systematic review","volume":"9","author":"Khoury","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/lary.20280","article-title":"Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients","volume":"119","author":"Devaiah","year":"2009","journal-title":"Laryngoscope"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hed.23327","article-title":"Optimization of long-term outcomes for patients with esthesioneuroblastoma","volume":"36","author":"Ow","year":"2014","journal-title":"Head Neck"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archotol.132.2.134","article-title":"Esthesioneuroblastoma: continued follow-up of a single institution\u2019s experience","volume":"132","author":"Loy","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archotol.129.11.1186","article-title":"Patterns of failure and outcome in esthesioneuroblastoma","volume":"129","author":"Dias","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archotol.133.3.276","article-title":"Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors","volume":"133","author":"Jethanamest","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0032-1311754","article-title":"Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study","volume":"73","author":"Patel","year":"2012","journal-title":"J Neurol Surg B Skull Base"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1288\/00005537-199011000-00013","article-title":"Esthesioneuroblastoma: surgical treatment without radiation","volume":"100","author":"Biller","year":"1990","journal-title":"Laryngoscope"},{"key":"R12-20230903","first-page":"2683","article-title":"Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924","volume":"17","author":"Broich","year":"1997","journal-title":"Anticancer Res"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/hed.20920","article-title":"Esthesioneuroblastoma: The Princess Margaret Hospital experience","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(01)00558-7","article-title":"Esthesioneuroblastoma: a meta-analysis and review","volume":"2","author":"Dulguerov","year":"2001","journal-title":"Lancet Oncol"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.wneu.2019.03.014","article-title":"Esthesioneuroblastoma: a comprehensive review of diagnosis, management and current treatment options","volume":"126","author":"Fiani","year":"2019","journal-title":"World Neurosurg"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archotol.1997.01900010038005","article-title":"Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases","volume":"123","author":"Bhattacharyya","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/1097-0142(19940515)73:10<2556::AID-CNCR2820731017>3.0.CO;2-S","article-title":"Esthesioneuroblastoma. Long-term outcome and patterns of failure\u2014the University of Virginia experience","volume":"73","author":"Eden","year":"1994","journal-title":"Cancer"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-008-9645-y","article-title":"Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma","volume":"90","author":"Porter","year":"2008","journal-title":"J Neurooncol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/hed.24822","article-title":"Outcomes for olfactory neuroblastoma treated with induction chemotherapy","volume":"39","author":"Su","year":"2017","journal-title":"Head Neck"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3171\/2010.2.JNS091897","article-title":"Posttreatment prognosis of patients with esthesioneuroblastoma","volume":"113","author":"Kane","year":"2010","journal-title":"J Neurosurg"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/alr.22027","article-title":"Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma","volume":"7","author":"Carey","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hed.25558","article-title":"Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma","volume":"41","author":"Miller","year":"2019","journal-title":"Head Neck"},{"key":"R23-20230903","first-page":"e4897","article-title":"Esthesioneuroblastoma: summary of single-center experiences with focus on adjuvant therapy and overall survival","volume":"11","author":"Alotaibi","year":"2019","journal-title":"Cureus"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12885-017-3247-z","article-title":"Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients","volume":"17","author":"Xiong","year":"2017","journal-title":"BMC Cancer"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/194589240201600512","article-title":"Factors predicting survival for cancer of the ethmoid sinus","volume":"16","author":"Bhattacharyya","year":"2002","journal-title":"Am J Rhinol"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/lary.27301","article-title":"A population-based analysis of nodal metastases in esthesioneuroblastomas of the sinonasal tract","volume":"129","author":"Kuan","year":"2019","journal-title":"Laryngoscope"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0003489418818586","article-title":"Factors associated with the improved survival of head and neck neuroblastomas compared to other body sites","volume":"128","author":"Kaufmann","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2500\/ajra.2015.29.4204","article-title":"Is sex an independent prognostic factor in esthesioneuroblastoma?","volume":"29","author":"Stokes","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoto.2014.2541","article-title":"Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis","volume":"140","author":"Tajudeen","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2147\/CMAR.S151945","article-title":"Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis","volume":"10","author":"Yin","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-6-41","article-title":"Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database","volume":"6","author":"Platek","year":"2011","journal-title":"Radiat Oncol"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1542\/peds.2007-1319","article-title":"Cancer of the nasal cavity in the pediatric population","volume":"121","author":"Benoit","year":"2008","journal-title":"Pediatrics"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L","article-title":"Olfactory neuroblastoma. A clinical analysis of 17 cases","volume":"37","author":"Kadish","year":"1976","journal-title":"Cancer"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","article-title":"Esthesioneuroblastoma: prognosis and management","volume":"32","author":"Morita","year":"1993","journal-title":"Neurosurgery"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with Medicare claims","volume":"54","author":"Noone","year":"2016","journal-title":"Med Care"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","article-title":"Misclassification in administrative claims data: quantifying the impact on treatment effect estimates","volume":"1","author":"Funk","year":"2014","journal-title":"Curr Epidemiol Rep"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.annepidem.2012.09.003","article-title":"Correcting for exposure misclassification using survival analysis with a time-varying exposure","volume":"22","author":"Ahrens","year":"2012","journal-title":"Ann Epidemiol"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00006123-199805000-00040","article-title":"Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience","volume":"42","author":"McElroy","year":"1998","journal-title":"Neurosurgery"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jso.25293","article-title":"Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma","volume":"119","author":"Joshi","year":"2019","journal-title":"Surg Oncol"},{"key":"R48-20230903","doi-asserted-by":"crossref","first-page":"52584","DOI":"10.18632\/oncotarget.9683","article-title":"Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment","volume":"7","author":"Czapiewski","year":"2016","journal-title":"Oncotarget"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:04:38Z","timestamp":1693713878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000649"}},"subtitle":["An Analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 Database"],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000649","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,6]]}}}